Evidence map›Paper›PMID 31061733›Full record

ArticleCardiology research and practice2019

Effects of Ivabradine on Residual Myocardial Ischemia after PCI Evaluated by Stress Echocardiography.

Simone Calcagno, Fabio Infusino, Olga Dettori, Temistocle Taccheri, Pasqualina Bruno, Viviana Maestrini, Gennaro Sardella, Massimo Mancone, Francesco Fedele

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiology research and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Ivabradine and endothelium: an update.Therapeutic advances in cardiovascular disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Simone CalcagnoCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Fabio InfusinoCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.ORCID 0000-0003-2606-657X
Olga DettoriCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Temistocle TaccheriCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Pasqualina BrunoCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Viviana MaestriniCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Gennaro SardellaCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Massimo ManconeCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-9602-0684
Francesco FedeleCardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.ORCID 0000-0003-2567-7918
Policlinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResidual angina after PCI is a frequently occurring disease. Ivabradine improves symptoms but its role in patients without left ventricular systolic dysfunction is still unclear. The aim was to quantify the effects of ivabradine in terms of MVO

methodsTwenty-eight consecutive patients with residual angina after PCI were randomized to ivabradine 5 mg twice/day (IG) or standard therapy (CG). All patients performed a stress echocardiography at the enrollment and after 30 days. MVO

resultsThe exercise time was longer in IG 9'49″ ± 48″ vs 8'09″ ± 59″ in CG (

conclusionsIvabradine seems to produce a significant improvement of ischemic threshold, chronotropic reserve, and diastolic function.

Identifiers

PMID31061733
PMCPMC6466911
OpenAlexW2931911950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.